• Explore /
  • Poster
  • / A phase II study of gemcitabine, erlotinib, and S-1 in patients with advanced pancreatic cancer.

A phase II study of gemcitabine, erlotinib, and S-1 in patients with advanced pancreatic cancer.

Abstract Poster

Authors

null

Boram Han

Hallym University Medical Center, Anyang, South Korea

Boram Han , Hyeong Su Kim , Dae Ro Choi , Byoungyong Shim , Kyung Hee Lee , Jin Won Kim , Jung Han Kim , Jung Hoon Kim , Hunho Song , Choong Kee Park , Sung Hoon Moon , Jong Hyeok Kim , Jang Yong Jeon , Jung Woo Lee , Dae Young Zang

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel and Hepatobiliary Tract

Track

Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Sub Track

Multidisciplinary Treatment

Clinical Trial Registration Number

NCT01693419

Citation

J Clin Oncol 35, 2017 (suppl 4S; abstract 476)

DOI

10.1200/JCO.2017.35.4_suppl.476

Abstract #

476

Poster Bd #

M16

Abstract Disclosures

Similar Posters

First Author: Dirk Strumberg

First Author: M. M. Javle

First Author: Tara Elisabeth Seery

First Author: Muhammad Shaalan Beg